1 and 2 July 2025 | Design Offices München Macherei
The innovation spotlight is on! Ahead of BayOConnect 2025 this summer, the featured start-ups and poster presentations are now set. Explore what’s next in biotech, medtech, and healthtech — and get ready to meet the minds behind tomorrow’s breakthroughs.
This year’s poster exhibition highlights early and advanced-stage research from universities and hospitals, as well as young companies, covering new methods for AI-driven antibody RNA-targeting, high-throughput analytics, next-gen diagnostics, and predictive biotherapeutic development. The curated display offers a window into the scientific pulse of Bavaria’s life science landscape. Discover how machine learning, novel biophysical tools, and synthetic biology are shaping the future of biotech.
The Start-up Pitch Session will take place from 11:30 to 12:30 p.m. on the main stage. Selected founders will step into the spotlight to present their groundbreaking innovations live, which cover innovative approaches in gene therapy, immunotolerance, radioligand therapy, AI-driven immuno-oncology, non-invasive cancer diagnostics, RNA-targeting small molecules, CRISPR-based point-of-care testing, small molecule RNA targeting, and sustainable solutions in agriculture and apiculture.
Who’s going to grab this year’s BayOConnect Start-up Award?
The most impressive start-up team will receive one free ticket to the BIO-Europe on 3-5 November in Vienna, sponsored by EBD Group.
Pioneering ideas address important health issues
2NA FISH: What if we could precisely capture disease-relevant RNA- and unlock a new era in targeted ADC bladder cancer therapy?
Alithea Bio: How can the development of precise and safe immunotherapies be revolutionized by combining immunopeptidomics, mass spectrometry, and artificial intelligence?
Berking Therapeutics: How can next-generation radioligand therapies revolutionize cancer treatment by using ultra-specific nanobodies to deliver radioisotopes directly to tumor cells?
BioExoTec: How can a simple saliva or blood test save lives by detecting cancer before symptoms appear—faster, cheaper, and without invasive biopsies?
Leopard Biosciences: How can an 'upside-down CRISPR' platform that flips the traditional diagnostic paradigm enable ultra-sensitive, multiplex testing at the point of care — bringing lab-quality results to the front lines of healthcare and strengthening global pandemic preparedness?
MarkHerz: How can cardiovascular-specific AAV vectors unlock a new era of precision gene therapy for vascular and metabolic diseases — moving beyond one-size-fits-all solutions in Cell & Gene Therapy?
Toleris: How can a new class of off-the-shelf biologics inspired by pregnancy unlock durable, antigen-specific immune tolerance—treating autoimmune disease without suppressing the entire immune system?
Tuari Therapeutics: Can targeting the overlooked RAL pathway downstream of KRAS unlock a mutation-independent, resistance-free strategy to treat millions of cancer patients where current therapies fail?
Varolis: Can a single-dose, residue-free lithium-based treatment finally solve the global Varroa crisis—offering sustainable protection for honeybee colonies without resistance or labor-intensive application?
xFOREST: Can an AI-ready screening platform that tests billions of RNA-compound combinations finally unlock precision small molecule drugs for undruggable genes—transforming RNA into the next frontier in drug discovery?
Start-ups and posters are now online: Explore the next generation of life science innovation
The tension is over: the selected start-ups and scientific posters for our upcoming event are now available online. Discover the most promising innovations and emerging ventures shaping the future of biotechnology and medicine.
Ready to discover?
Explore the posters and start-ups
Listen to the pitches live: Register now to attend BayOConnect 2025